Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Scarfò

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
European Journal of Internal Medicine|October 1, 2018
Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?Piera Angelillo, Antonella Capasso, Paolo Ghia, et al.
Critical Reviews in Oncology/Hematology|July 3, 2016
Chronic lymphocytic leukaemiaLydia Scarfò, Andrés J M Ferreri, Paolo Ghia
Seminars in Cancer Biology|April 19, 2026
Therapy-driven clonal dynamics in chronic lymphocytic leukemiaLarry Mansouri, Thomas Chatzikonstantinou, Lydia Scarfò, et al.
Leukemia & Lymphoma|January 11, 2021
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemiaPaolo Ghia, Monika Dlugosz-Danecka, Lydia Scarfò, et al.
Seminars in Cancer Biology|September 7, 2010
CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?Lydia Scarfò, Antonis Dagklis, Cristina Scielzo, et al.
Seminars in Cancer Biology|January 29, 2022
Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemiaElisa Albi, Antonella Capasso, Luana Schiattone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic LeukemiaAlessandra Rovida, Cristina Maccalli, Lydia Scarfò, et al.
Cancer Journal (Sudbury, Mass.)|August 16, 2021
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand NowThomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, et al.
Hematological Oncology|June 15, 2025
Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not NeglectAndrea Serafin, Emanuela Sant'Antonio, Fabrizio Mavilia, et al.
Hemasphere|September 9, 2022
What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice ExperimentLuca Laurenti, Gianluca Gaidano, Francesca Romana Mauro, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
European Journal of Internal Medicine|October 1, 2018
Monoclonal B-cell lymphocytosis: Does the elderly patient need a specialistic approach?Piera Angelillo, Antonella Capasso, Paolo Ghia, et al.
Critical Reviews in Oncology/Hematology|July 3, 2016
Chronic lymphocytic leukaemiaLydia Scarfò, Andrés J M Ferreri, Paolo Ghia
Seminars in Cancer Biology|April 19, 2026
Therapy-driven clonal dynamics in chronic lymphocytic leukemiaLarry Mansouri, Thomas Chatzikonstantinou, Lydia Scarfò, et al.
Leukemia & Lymphoma|January 11, 2021
Acalabrutinib: a highly selective, potent Bruton tyrosine kinase inhibitor for the treatment of chronic lymphocytic leukemiaPaolo Ghia, Monika Dlugosz-Danecka, Lydia Scarfò, et al.
Seminars in Cancer Biology|September 7, 2010
CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?Lydia Scarfò, Antonis Dagklis, Cristina Scielzo, et al.
Seminars in Cancer Biology|January 29, 2022
Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemiaElisa Albi, Antonella Capasso, Luana Schiattone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic LeukemiaAlessandra Rovida, Cristina Maccalli, Lydia Scarfò, et al.
Cancer Journal (Sudbury, Mass.)|August 16, 2021
COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand NowThomas Chatzikonstantinou, Yair Herishanu, Emili Montserrat, et al.
Hematological Oncology|June 15, 2025
Monoclonal B-Cell Lymphocytosis: The Silent Clone the Haematologists Should Not NeglectAndrea Serafin, Emanuela Sant'Antonio, Fabrizio Mavilia, et al.
Hemasphere|September 9, 2022
What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice ExperimentLuca Laurenti, Gianluca Gaidano, Francesca Romana Mauro, et al.
Pageof 15